BioIntelliSense and Renown Health Announce Strategic Collaboration to Provide Continuous Medical Grade Patient Monitoring from In-Hospital to Home DENVER and RENO, Nev., Dec. 06, 2021 (GLOBE NEWSWIRE) -- BioIntelliSense, a continuous health monitoring and clinical intelligence company, has entered into a strategic collaboration with Renown...

Joerns Healthcare and BioIntelliSense Announce North American Partnership to Expand Access to Innovative, Medical Grade Wearable Devices for Continuous Remote Monitoring, Enabling Patient Care Anywhere CHARLOTTE, N.C. and DENVER, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Joerns Healthcare, a healthcare technology and equipment services company, announced today that they have entered into a strategic...

Myia Health and BioIntelliSense Partner to Integrate Continuous Vital Sign Monitoring Into the Myia Platform SAN FRANCISCO and DENVER, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Myia Health, an enterprise platform for virtual health care delivery in the home, and BioIntelliSense, a continuous health monitoring and...

BioIntelliSense Honored by Goldman Sachs for Entrepreneurship DENVER, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Goldman Sachs (NYSE:GS) is recognizing BioIntelliSense for Entrepreneurship and Founder and CEO, James Mault, MD, as one of the 100 Most Intriguing...

Jasper Health and BioIntelliSense Form Strategic Collaboration to Transform Remote Monitoring for Oncology Care Jasper Health will integrate the BioIntelliSense FDA-cleared BioSticker™ and medical grade BioButton® wearable devices as part of its remote member engagement and guidance platformJasper Health and...